Trial Details
COMPLETEDBasic Information
| Clinical ID | c1408 |
|---|---|
| Identifier | NCT02606032 |
| Trial Title | Trial of Antimicrobials Versus Placebo in Addition to Fecal Transplant Therapy in Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Metronidazole|DRUG: Doxycycline|DRUG: Terbinafine|DRUG: Placebo |
Participant Information
| Sponsor | Hamilton Health Sciences Corporation |
|---|---|
| City | Hamilton |
| Country/Region | Canada |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-05-16 |
|---|---|
| Primary Completion Date | 2025-01-21 |
| Completion Date | 2021-01-27 |